Finance

Lists
ELAN:NYSE
Elanco Animal Health Inc
$26.29
-1.54%
(-0.41) 1D
$26.25
-0.15% (-0.040)
Pre-market
Closed: Nov 19, 4:00:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELAN...
Open
$27.25
High
$27.49
Low
$26.28
Mkt. cap
13.14B
Avg. vol.
5.21M
Volume
379.00
52-wk high
$27.98
52-wk low
$19.40
EPS
-$0.32
Beta
1.73
Shares outstanding
499.83M
No. of employees
10K
Open
$27.25
High
$27.49
Low
$26.28
Mkt. cap
13.14B
Avg. vol.
5.21M
Volume
379.00
52-wk high
$27.98
52-wk low
$19.40
EPS
-$0.32
Beta
1.73
Shares outstanding
499.83M
No. of employees
10K
News stories
From web sources and news partners
Profile
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
About Elanco Animal Health Inc
CEOJeffrey N. Simmons
Employees9.65K
Founded1954
HeadquartersIndianapolis, Indiana, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteelanco.com
Analyst ratings
Based on 11 analysts giving stock ratings to ELAN in the past 3 months
Strong buy
Buy
9
Hold
2
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ELAN in the last 3 months.
Highest
Current $26.29
$35.00 (+33.13%)
Average
$31.09 (+18.26%)
Lowest
$24.00 (-8.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Glen Santangelo
Barclays
Buy
Maintained
$32.00
+21.7%
11/18/2026
Andrea Alfonso
UBS
Buy
Reiterated
$35.00
+33.1%
11/09/2026
Jonathan Block
Stifel Nicolaus
Buy
Reiterated
$33.00
+25.5%
11/09/2026
David Westenberg
Piper Sandler
Buy
Maintained
$30.00
+14.1%
11/09/2026
Chris Schott
J.P. Morgan
Buy
Reiterated
$35.00
+33.1%
11/09/2026
Scott Schoenhaus
KeyBanc
Buy
Reiterated
$30.00
+14.1%
11/09/2026
Erin Wright
Morgan Stanley
Hold
Maintained
$25.00
-4.9%
10/30/2026
Keith Devas
Jefferies
Hold
Downgraded
$24.00
-8.7%
10/20/2026
Matthew Dellatorre
Goldman Sachs
Buy
Initiated
$32.00
+21.7%
10/15/2026
Daniel Clark
Leerink Partners
Buy
Reiterated
$34.00
+29.3%
10/01/2026
Steve Scala
TD Cowen
Buy
Reiterated
$32.00
+21.7%
08/25/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
$34.00
+29.3%
08/12/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/12/2026
Daniel Grosslight
Citi
Buy
Maintained
$34.00
+29.3%
08/06/2026
Jasper Hellweg
Argus Research
Buy
Maintained
-
-
06/23/2026
Umer Raffat
Evercore ISI
Buy
Maintained
-
-
05/11/2026
Unknown Analyst
Jefferies
Buy
Maintained
$30.00
+14.1%
02/25/2026
Last report
Nov 6, 2026
Fiscal period
Q3 2026
$0.27 / $0.20
+32.82%beat
Revenue / Est. (USD)
1.26B / 1.21B
+4.82%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.14B
1.37B
1.37B
1.26B
Cost of goods sold
555.00M
586.00M
570.00M
545.00M
Cost of revenue
555.00M
586.00M
570.00M
545.00M
Research and development expenses
93.00M
97.00M
92.00M
99.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
331.00M
381.00M
449.00M
393.00M
Operating expense
563.00M
616.00M
680.00M
636.00M
Total operating expenses
1.12B
1.20B
1.25B
1.18B
Operating income
26.00M
169.00M
118.00M
84.00M
Other non operating income
-15.00M
-8.00M
-11.00M
25.00M
EBT including unusual items
-259.00M
87.00M
56.00M
24.00M
EBT excluding unusual items
-37.00M
103.00M
65.00M
27.00M
Income tax expense
17.00M
30.00M
2.00M
6.00M
Effective tax rate
-6.56%
34.48%
3.57%
25.00%
Other operating expenses
-
-
-
-
Net income
-276.00M
57.00M
54.00M
18.00M
Net profit margin
-24.13%
4.16%
3.95%
1.42%
Earnings per share
0.13
0.40
0.34
0.27
Interest and investment income
45.00M
-
-
-
Interest expense
-105.00M
-57.00M
-59.00M
-59.00M
Net interest expenses
-60.00M
-57.00M
-59.00M
-59.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
194.00M
335.00M
283.00M
255.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps